Atabak Mokari - Chief Financial Officer at Corcept Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CORT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Atabak Mokari since 12/22/2023

Holdings reported by Atabak Mokari for Corcept Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 12.8K $758K $59.21 Dec 2, 2024 Direct
Stock option (right to buy) 200K Feb 9, 2024 Direct Common Stock

Transactions reported by Atabak Mokari for Corcept Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.